Decline in anti-M üllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis
Thyroid cancer is the most common endocrine malignancy, accounting for 1 –2% of all cancers [1]. Its incidence has increased during the last two decades (from 7.1 cases per 100,000 in 2000 to 17.6 cases per 100,000 in 2013 in the United States) [2], probably due to the increased use of ultrasonography and other imaging modalities for screening [3]. Concerning females, thyroid cancer incidence for the period 1975–2009 increased from 6.5 to 14.9 cases per 100,000 women [4], ranking it as the third most common type of female malignancy [4,5].
Source: Maturitas - Category: Primary Care Authors: Panagiotis Anagnostis, Panagiota Florou, Julia K. Bosdou, Grigorios F. Grimbizis, Ioannis Iakovou, Efstratios M. Kolibianakis, Dimitrios G. Goulis Tags: Review article Source Type: research
More News: Cancer | Cancer & Oncology | Hormones | Iodine | Primary Care | Thyroid | Thyroid Cancer | USA Health | Women